Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID VA24813F0053· VHA· 248-NETWORK CONTRACT OFFICE 8· 6505 · DRUGS AND BIOLOGICALS· FY2013· $300,289 net obligations· UEI DKCXLGANZAN3· CT

Description

DIRECT PATIENT CARE - EMERGENCY CHEMO DRUG

First action · last action
2012-10-16 · 2013-11-21
Transactions
3
First transaction's obligation
$146,693
Base + all options value (sum of deltas)
$300,289
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5942X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$325,550$0Base award · 2012-10-16 · this action $146,693 · running total $146,693Modification P00001 · 2013-03-26 · this action $178,857 · running total $325,550Modification P00002 · 2013-11-21 · this action -$25,261 · running total $300,289
  • Base2012-10-16+$146,693= $146,693
  • Mod P000012013-03-26+$178,857= $325,550
  • Mod P000022013-11-21-$25,261= $300,289
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-10-16+$146,693$146,693DIRECT PATIENT CARE - EMERGENCY CHEMO DRUG
Mod P00001· CHANGE ORDER2013-03-26+$178,857$325,550DIRECT PATIENT CARE - EMERGENCY CHEMO DRUG
Mod P00002· FUNDING ONLY ACTION2013-11-21−$25,261$300,289DIRECT PATIENT CARE - EMERGENCY CHEMO DRUG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36F79726D0143NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24816J2789CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8$25,056FY2016
VA24816J2780CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8$102,089FY2016
VA24816F1279CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8$22,016FY2016
VA24816P1268MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$16,913FY2016
VA24816P1163MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$10,115FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24813F0053_3600_V797P5942X_3600 · retrieved 2026-09-26.